A refill for the brain mineralocorticoid receptor: The benefit of cortisol add-on to dexamethasone therapy

Endocrinology

Volumn 158, Issue 3, 2017, Pages 448-454

  Meijer, Onno C ^a,b   De Kloet, E Ronald ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; GLUCOCORTICOID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADD ON THERAPY; DRUG BINDING; DRUG EFFICACY; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE RELEASE; LOW DRUG DOSE; MULTICENTER STUDY (TOPIC); NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOLOGICAL WELL-BEING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDER; TREATMENT DURATION; AGONISTS; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; MENTAL DISORDERS; METABOLISM; PHYSIOLOGICAL FEEDBACK;

BRAIN; DEXAMETHASONE; FEEDBACK, PHYSIOLOGICAL; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MENTAL DISORDERS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID;

EID: 85014443691     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1495     Document Type: Review

References (72)

1. Hockey B, Leslie K, Williams D. Dexamethasone for intracranial neurosurgery and anaesthesia. J Clin Neurosci. 2009;16(11): 1389-1393.
2. Strehl C, Bijlsma JWJ, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TWJ, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, Scherer HU, Seror R, Spies CM, Tarp S, Wiek D, Winthrop KL, Buttgereit F. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Ann Rheum Dis. 2016;75(6):952-957.
3. Judd LL, Schettler PJ, Brown ES, Wolkowitz OM, Sternberg EM, Bender BG, Bulloch K, Cidlowski JA, de Kloet ER, Fardet L, Jöels M, Leung DYM, McEwen BS, Roozendaal B, Van Rossum EFC, Ahn J, Brown DW, Plitt A, Singh G. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry. 2014; 171(10):1045-1051.
4. Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, Pluijm SMF, Bierings MB, van den Bos C, Zwaan CM, Thygesen HH, Tissing WJE, Veening MA, Pieters R, van den Akker ELT. Hydrocortisone as an intervention for dexamethasone-induced adverse effects in pediatric patients with acute lymphoblastic leukemia: results of a double-blind, randomized controlled trial. J Clin Oncol. 2016; 34(19):2287-2293.
5. Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169(5):491-497.
6. de Kloet ER. From receptor balance to rational glucocorticoid therapy. Endocrinology. 2014;155(8):2754-2769.
7. West CD, Mahajan DK, Chavré VJ, Nabors CJ, Tyler FH. Simultaneous measurement of multiple plasma steroids by radioimmunoassay demonstrating episodic secretion. J Clin Endocrinol Metab. 1973;36(6):1230-1236.
8. Underwood RH, Williams GH. The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med. 1972;79(5): 848-862.
9. Sarabdjitsingh RA, Jezequel J, Pasricha N, Mikasova L, Kerkhofs A, Karst H, Groc L, Jöels M. Ultradian corticosterone pulses balance glutamatergic transmission and synaptic plasticity. Proc Natl Acad Sci USA. 2014;111(39):14265-14270.
10. Evans RM, Arriza JL. A molecular framework for the actions of glucocorticoid hormones in the nervous system. Neuron. 1989; 2(2):1105-1112.
11. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985;117(6):2505-2511.
12. Wyrwoll CS, Holmes MC, Seckl JR. 11β-Hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol. 2011;32(3):265-286.
13. Funder JW. Mineralocorticoid receptors: distribution and activation. Heart Fail Rev. 2005;10(1):15-22.
14. Geerling JC, Kawata M, Loewy AD. Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol. 2006;494(3): 515-527.
15. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol. 2009;297(3):F559-F576.
16. Reul JM, van den Bosch FR, de Kloet ER. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol. 1987;115(3):459-467.
17. Jöels M, Sarabdjitsingh RA, Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol Rev. 2012;64(4):901-938.
18. Beck IME, Vanden Berghe W, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher K. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev. 2009;30(7):830-882.
19. Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AFH, Diederich S, Bahr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004;151(3): 397-406.
20. de Kloet ER, van der Vies J, de Wied D. The site of the suppressive action of dexamethasone on pituitary-adrenal activity. Endocrinology. 1974;94(1):61-73.
21. De Kloet R, Wallach G, McEwen BS. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology. 1975;96(3):598-609.
22. Schmidt MV, Sterlemann V, Wagner K, Niederleitner B, Ganea K, Liebl C, Deussing JM, Berger S, Schütz G, Holsboer F, Müller MB. Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences. Endocrinology. 2009;150(6):2709-2716.
23. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, de Kloet ER. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology. 1998;139(4):1789-1793.
24. Karssen AM, Meijer OC, van der Sandt ICJ, De Boer AG, De Lange ECM, De Kloet ER. The role of the efflux transporter Pglycoprotein in brain penetration of prednisolone. J Endocrinol. 2002;175(1):251-260.
25. Karssen AM, Meijer OC, Berry A, Sanjuan Piñol R, de Kloet ER. Low doses of dexamethasone can produce a hypocorticosteroid state in the brain. Endocrinology. 2005;146(12):5587-5595.
26. de Kloet ER, Jöels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463-475.
27. Oitzl MS, de Kloet ER. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci. 1992;106(1):62-71.
28. Jöels M, Karst H, DeRijk R, de Kloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008;31(1): 1-7.
29. Schwabe L, Tegenthoff M, Höffken O, Wolf OT. Mineralocorticoid receptor blockade prevents stress-induced modulation of multiple memory systems in the human brain. Biol Psychiatry. 2013;74(11):801-808.
30. Schwabe L, Tegenthoff M, Höffken O, Wolf OT. Concurrent glucocorticoid and noradrenergic activity shifts instrumental behavior from goal-directed to habitual control. J Neurosci. 2010; 30(24):8190-8196.
31. Vogel S, Klumpers F, Krugers HJ, Fang Z, Oplaat KT, Oitzl MS, Jöels M, Fernández G. Blocking the mineralocorticoid receptor in humans prevents the stress-induced enhancement of centromedial amygdala connectivity with the dorsal striatum. Neuropsychopharmacology. 2014;40947-956.
32. Vogel S, Fernández G, Jöels M, Schwabe L. Cognitive adaptation under stress: a case for the mineralocorticoid receptor. Trends Cogn Sci. 2016;20(3):192-203.
33. Hermans EJ, Henckens MJAG, Jöels M, Fernández G. Dynamic adaptation of large-scale brain networks in response to acute stressors. Trends Neurosci. 2014;37(6):304-314.
34. Fuxe K, Härfstrand A, Agnati LF, Yu ZY, Cintra A, Wikström AC, Okret S, Cantoni E, Gustafsson JA. Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor. Neurosci Lett. 1985;60(1):1-6.
35. Fuxe K, Wikström AC, Okret S, Agnati LF, Härfstrand A, Yu ZY, Granholm L, Zoli M, Vale W, Gustafsson JA. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology. 1985;117(5):1803-1812.
36. Jöels M. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol Sci. 2006;27(5):244-250.
37. Gesmundo I, Villanova T, Gargantini E, Arvat E, Ghigo E, Granata R. The mineralocorticoid agonist fludrocortisone promotes survival and proliferation of adult hippocampal progenitors. Front Endocrinol (Lausanne). 2016;7:66.
38. Nieman LK, Chrousos GP, Kellner C, Spitz IM, Nisula BC, Cutler GB, Merriam GR, Bardin CW, Loriaux DL. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab. 1985;61(3):536-540.
39. Mifsud KR, Reul JMHM. Acute stress enhances heterodimerization and binding of corticosteroid receptors at glucocorticoid target genes in the hippocampus. Proc Natl Acad Sci USA. 2016;113(40):11336-11341.
40. Trapp T, Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptors increases the functional diversity of corticosteroid action. Trends Pharmacol Sci. 1996;17(4):145-149.
41. Le Billan F, Khan JA, Lamribet K, Viengchareun S, Bouligand J, Fagart J, Lombès M. Cistrome of the aldosterone-activated mineralocorticoid receptor in human renal cells. FASEB J. 2015;29(9): 3977-3989.
42. Meinel S, Ruhs S, Schumann K, Strätz N, Trenkmann K, Schreier B, Grosse I, Keilwagen J, Gekle M, Grossmann C. Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression. Nucleic Acids Res. 2013;41(17):8045-8060.
43. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 1993;259(5098):1161-1165.
44. Meijer OC, Williamson A, Dallman MF, Pearce D. Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context. J Neuroendocrinol. 2000;12(3):245-254.
45. Yang J, Fuller PJ, Morgan J, Shibata H, McDonnell DP, Clyne CD, Young MJ. Use of phage display to identify novel mineralocorticoid receptor-interacting proteins. Mol Endocrinol. 2014;28(9): 1571-1584.
46. Zalachoras I, Houtman R, Atucha E, Devos R, Tijssen AMI, Hu P, Lockey PM, Datson NA, Belanoff JK, Lucassen PJ, Jöels M, de Kloet ER, Roozendaal B, Hunt H, Meijer OC. Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. Proc Natl Acad Sci USA. 2013;110(19):7910-7915.
47. Polman JAE, de Kloet ER, Datson NA. Two populations of glucocorticoid receptor-binding sites in the male rat hippocampal genome. Endocrinology. 2013;154(5):1832-1844.
48. Liston C, Cichon JM, Jeanneteau F, Jia Z, Chao MV, Gan W-B. Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance. Nat Neurosci. 2013;16(6):698-705.
49. Liston C, Gan W-B. Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc Natl Acad Sci USA. 2011;108(38):16074-16079.
50. Born J, DeKloet ER, Wenz H, Kern W, Fehm HL. Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol. 1991;260(2 Pt 1): E183-E188.
51. Groch S, Wilhelm I, Lange T, Born J. Differential contribution of mineralocorticoid and glucocorticoid receptors to memory formation during sleep. Psychoneuroendocrinology. 2013;38(12): 2962-2972.
52. Plihal W, Krug R, Pietrowsky R, Fehm HL, Born J. Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology. 1996;21(6):515-523.
53. Stuart FA, Segal TY, Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child. 2005; 90(5):500-506.
54. Warris LT, van den Akker ELT, Aarsen FK, Bierings MB, van den Bos C, Tissing WJE, Sassen SDT, Veening MA, Zwaan CM, Pieters R, van den Heuvel-Eibrink MM. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia. Psychoneuroendocrinology. 2016;72:190-195.
55. Warris LT, van den Akker ELT, Bierings MB, van den Bos C, Zwaan CM, Sassen SDT, Tissing WJE, Veening MA, Pieters R, van den Heuvel-Eibrink MM. Acute activation of metabolic syndrome components in pediatric acute lymphoblastic leukemia patients treated with dexamethasone. PLoS One. 2016;11(6):e0158225.
56. de Ruiter RD, Gordijn MS, Gemke RJBJ, van den Bos C, Bierings MB, Rotteveel J, Koper JW, van Rossum EFC, Kaspers GL. Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI. Haematologica. 2014; 99(8):e136-e137.
57. Zannas AS, Binder EB. Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism. Genes Brain Behav. 2014;13(1):25-37.
58. Klok MD, Giltay EJ, Van der Does AJW, Geleijnse JM, Antypa N, Penninx BWJH, de Geus EJC, Willemsen G, Boomsma DI, van Leeuwen N, Zitman FG, de Kloet ER, DeRijk RH. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl Psychiatry. 2011;1:e62.
59. DeRijk RH, Wüst S, Meijer OC, Zennaro M-C, Federenko IS, Hellhammer DH, Giacchetti G, Vreugdenhil E, Zitman FG, de Kloet ER. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab. 2006;91(12):5083-5089.
60. Bogdan R, Williamson DE, Hariri AR. Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. Am J Psychiatry. 2012;169(5):515-522.
61. Levine S. Infantile experience and resistance to physiological stress. Science. 1957;126(3270):405.
62. Turecki G, Meaney MJ. Effects of the social environment and stress on glucocorticoid receptor gene methylation: a systematic review. Biol Psychiatry. 2016;79(2):87-96.
63. Sousa N. The dynamics of the stress neuromatrix. Mol Psychiatry. 2016;21(3):302-312.
64. Datson NA, van den Oever JME, Korobko OB, Magarinos AM, de Kloet ER, McEwen BS. Previous history of chronic stress changes the transcriptional response to glucocorticoid challenge in the dentate gyrus region of the male rat hippocampus. Endocrinology. 2013;154(9):3261-3272.
65. Gray JD, Rubin TG, Hunter RG, McEwen BS. Hippocampal gene expression changes underlying stress sensitization and recovery. Mol Psychiatry. 2014;19(11):1171-1178.
66. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386-389.
67. de Kloet ER, Otte C, Kumsta R, Kok L, Hillegers MHJ, Hasselmann H, Kliegel D, Jöels M. Stress and depression a crucial role of the mineralocorticoid receptor. J Neuroendocrinol. 2016;28(8) doi: 10.1111/jne.12379.
68. Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, de Kloet ER. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology. 2001;142(6):2686-2694.
69. Gerlach JL, McEwen BS, Pfaff DW, Moskovitz S, Ferin M, Carmel PW, Zimmerman EA. Cells in regions of rhesus monkey brain and pituitary retain radioactive estradiol, corticosterone and cortisol differentially. Brain Res. 1976;103(3):603-612.
70. McEwen BS, de Kloet R, Wallach G. Interactions in vivo and in vitro of corticoids and progesterone with cell nuclei and soluble macromolecules from rat brain regions and pituitary. Brain Res. 1976;105(1):129-136.
71. Solomon MB, Sakai RR, Woods SC, Foster MT. Differential effects of glucocorticoids on energy homeostasis in Syrian hamsters. Am J Physiol Endocrinol Metab. 2011;301(2):E307-E316.
72. Nixon M, Mackenzie SD, Taylor AI, Homer NZ, Livingstone DE, Mouras R, Morgan RA, Mole DJ, Stimson RH, Reynolds RM, Elfick AP, Andrew R, Walker BR. ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy. Sci Transl Med. 2016;8(352): 352ra109.